PHIP is a subunit of the CUL4-RING ubiquitin ligase complex that functions as a probable regulator of insulin and insulin-like growth factor signaling pathways. It stimulates cell proliferation through cyclin transcription regulation and exhibits anti-apoptotic activity via AKT1 phosphorylation and activation. PHIP possesses histone reader activity and regulates cell morphology, cytoskeletal organization, and mitotic nuclear division through protein binding interactions in the nucleus. Mechanistically, PHIP acts as a positive regulator of transcription by RNA polymerase II and plays roles in negating both intrinsic and extrinsic apoptotic pathways while promoting insulin receptor signaling. Its functions span cell proliferation regulation, protein phosphorylation modulation, and replication fork processing. Clinically, PHIP mutations are associated with Chung-Jansen syndrome. However, the provided abstracts focus on PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine), a heterocyclic amine dietary carcinogen distinct from the PHIP gene product. These abstracts document PhIP's metabolism, DNA adduct formation, carcinogenic potential in breast and colon tissues, and chemopreventive strategies—none of which directly address PHIP gene function or disease mechanisms. The gene symbol overlap creates potential nomenclature confusion that should be clarified.